A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

NCT05497297 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: HSK7653 tablets

Sponsor

Haisco Pharmaceutical Group Co., Ltd.